Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.19.1
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Concentration Risk [Line Items]    
Revenues $ 90,202 $ 79,051
U.S. revenue    
Concentration Risk [Line Items]    
Revenues 70,399 62,145
Non-U.S. revenue    
Concentration Risk [Line Items]    
Revenues $ 19,803 $ 16,906